A Comparison of Home Management Methods to Improve Outcomes for African-American Patients with Chronic Heart Failure

2.50
Hdl Handle:
http://hdl.handle.net/10755/147841
Type:
Presentation
Title:
A Comparison of Home Management Methods to Improve Outcomes for African-American Patients with Chronic Heart Failure
Abstract:
A Comparison of Home Management Methods to Improve Outcomes for African-American Patients with Chronic Heart Failure
Conference Sponsor:Sigma Theta Tau International
Conference Year:2007
Author:Bondmass, Mary D., RN, PhD
P.I. Institution Name:University of Nevada Las Vegas
Title:Assistant Professor
[Clinical session research presentation] BACKGROUND: Home management of chronic heart failure (CHF) continues to challenge health care providers. This is of particular concern for African American (AA) patients, who have higher incidence rates of CHF compared to Caucasians. PURPOSE: The purpose of this study was to compare two home management methods to determine which was more efficacious at improving selected biopsychosocial outcomes for AA patients with CHF.    METHODS: A prospective randomized design was used for this study. Prior to discharge from a HF hospitalization, 186 AA patients, New York Heart Association (NYHA) functional class III-IV, were randomized to receive one of two home interventions for management of their CHF. Subjects received either home monitoring with telemanagement (HMT) (n = 90, mean 62.1 +/- 13.6 yrs, 63.3 % female) or home nurse visits (HNV) (n = 96, mean 62.8 +/- 12.4 yrs, 60.4% female). Outcomes, measured at three months post intervention, included HF self-efficacy, quality of life, psychological and symptom distress. Wilcoxon-Mann-Whitney U, Chi-square, and ANOVA tests was used for between-group analyses relative to the level and distribution of the data. RESULTS: No significant baseline differences were found between the groups for age, gender, NYHA functional class, left ventricular ejection fraction, or insurance provider.  Following the intervention period, patients who were in the HMT group had significantly higher overall scores for self-efficacy (p = equal to or less than 0.000) and quality of life (p = equal to or less than 0.000), and lower scores for psychological and symptom distress (p = equal to or less than 0.000) compared to patients in the HNV group. Additionally, intervention costs were significantly lower (p = equal to or less than 0.000)   for the HMT group.  CONCLUSION: These data suggest that home monitoring with telemanagement may be more efficacious when compared to home nurse visits at improving certain biopsychosocial outcomes, at lower intervention costs, for the home management of CHF for African American patients.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleA Comparison of Home Management Methods to Improve Outcomes for African-American Patients with Chronic Heart Failureen_GB
dc.identifier.urihttp://hdl.handle.net/10755/147841-
dc.description.abstract<table><tr><td colspan="2" class="item-title">A Comparison of Home Management Methods to Improve Outcomes for African-American Patients with Chronic Heart Failure</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2007</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Bondmass, Mary D., RN, PhD</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">University of Nevada Las Vegas</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Assistant Professor</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">mary.bondmass@unlv.edu</td></tr><tr><td colspan="2" class="item-abstract">[Clinical session research presentation] BACKGROUND: Home management of chronic heart failure (CHF) continues to challenge health care providers. This is of particular concern for African American (AA) patients, who have higher incidence rates of CHF compared to Caucasians. PURPOSE: The purpose of this study&nbsp;was to compare two home management methods to determine which&nbsp;was more efficacious at improving selected biopsychosocial outcomes for AA patients with CHF. &nbsp;&nbsp;&nbsp;METHODS: A prospective randomized design was used for this study. Prior to discharge from a HF hospitalization, 186 AA patients, New York Heart Association (NYHA) functional class III-IV, were randomized to receive one of two home interventions for management of their CHF. Subjects received either home monitoring with telemanagement (HMT) (n = 90, mean 62.1 +/- 13.6 yrs, 63.3 % female) or home nurse visits (HNV) (n = 96, mean 62.8 +/- 12.4 yrs, 60.4% female). Outcomes, measured at three months post intervention, included HF self-efficacy, quality of life, psychological and symptom distress. Wilcoxon-Mann-Whitney U, Chi-square, and ANOVA tests was used for between-group analyses relative to the level and distribution of the data. RESULTS: No significant baseline differences were found between the groups for age, gender, NYHA functional class, left ventricular ejection fraction, or insurance provider.&nbsp; Following the intervention period, patients who were in the HMT group had significantly higher overall scores for self-efficacy (p = equal to or less than 0.000) and quality of life (p = equal to or less than 0.000), and lower scores for psychological and symptom distress (p = equal to or less than 0.000) compared to patients in the HNV group. Additionally, intervention costs were significantly lower (p = equal to or less than 0.000)&nbsp;&nbsp; for the HMT group. &nbsp;CONCLUSION: These data suggest that home monitoring with telemanagement may be more efficacious when compared to home nurse visits at improving certain biopsychosocial outcomes, at lower intervention costs, for the home management of CHF for African American patients.</td></tr></table>en_GB
dc.date.available2011-10-26T09:37:02Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T09:37:02Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.